Patents by Inventor Xiaoxue Wen

Xiaoxue Wen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240121771
    Abstract: A scheduling electronic device is used for selecting a candidate time-frequency resource set required for communication of a predetermined electronic device in the group to which the scheduling electronic device belongs; and the scheduling electronic device comprises a processing circuit, and the processing circuit is configured to: receive, from at least one member electronic device located in an overlapping region between said group and other groups, a cooperative sensing result obtained by sensing a time-frequency resource by the at least one member electronic device during at least a portion of a cooperative resource sensing window, so as to assist the scheduling electronic device in selecting a candidate time-frequency resource set, the cooperative resource sensing window being a time period for the at least one member electronic device to perform the assistance so as to sense the time-frequency resource.
    Type: Application
    Filed: April 12, 2022
    Publication date: April 11, 2024
    Applicant: Sony Group Corporation
    Inventors: Yanzhao HOU, Xiaofeng TAO, Yang WEN, Chengrui WANG, Yinan GUO, Xiaoxue WANG, Chen SUN
  • Patent number: 9642839
    Abstract: Disclosed in the present disclosure are substances having tyrosine kinase inhibitory activity and a preparation method and use thereof, wherein the substances are the compounds having the structure of general formula (I) or the geometric isomers or pharmaceutical salts thereof. Through evaluation on tyrosine kinase inhibitory activity and related experiments, the present disclosure demonstrates that these compounds have a good tyrosine kinase inhibitory activity, and may inhibit a variety of tumor cells, and thus may be developed into drugs for preventing and treating tumor diseases, especially liver cancer, lung cancer and neuroblastoma.
    Type: Grant
    Filed: June 20, 2013
    Date of Patent: May 9, 2017
    Assignee: Institute of Radiation Medicine, China Academy of Military Medical Sciences Pla
    Inventors: Xiaoming Yang, Lin Wang, Changyan Li, Yiqun Zhan, Jing Liu, Teng Luo, Haiyan Yan, Shouguo Zhang, Wei Li, Xiaoxue Wen, Tao Peng, Lu Li
  • Publication number: 20160151334
    Abstract: Disclosed in the present disclosure are substances having tyrosine kinase inhibitory activity and a preparation method and use thereof, wherein the substances are the compounds having the structure of general formula (I) or the geometric isomers or pharmaceutical salts thereof. Through evaluation on tyrosine kinase inhibitory activity and related experiments, the present disclosure demonstrates that these compounds have a good tyrosine kinase inhibitory activity, and may inhibit a variety of tumor cells, and thus may be developed into drugs for preventing and treating tumor diseases, especially liver cancer, lung cancer and neuroblastoma.
    Type: Application
    Filed: June 20, 2013
    Publication date: June 2, 2016
    Applicant: INSTITUTE OF RADIATION MEDICINE, CHINA ACADEMY OF MILITARY MEDICAL SCIENCES PLA
    Inventors: Xiaoming Yang, Lin Wang, Changyan Li, Yiqun Zhan, Jing Liu, Teng Luo, Haiyan Yan, Shouguo Zhang, Wei Li, Xiaoxue Wen, Tao Peng, Lu Li